Neuphoria Therapeutics Inc. · NASDAQ:NEUP

Baselake Partners, LP reported a 9.40% stake in Neuphoria Therapeutics Inc. (Schedule 13G)

Event Oct 27, 2025 · Filed Oct 31, 2025

Baselake Partners, LP reported a 9.40% stake in Neuphoria Therapeutics Inc., 222,222 shares, as a passive investor on Oct 27, 2025. Filed Oct 31, 2025 (Schedule 13G).

Stake
9.40%
Shares
222,222
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Baselake Partners, LP9.40%222,222
Baselake Management, LLC9.40%222,222
David Paolella9.40%222,222

Source

View original at SEC

Related